-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $67

Benzinga·07/16/2026 18:10:07
语音播报
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target from $69 to $67.